Company:  ASTEX PHARMACEUTICALS, IN ...
Form Type:  8-K
Filing Date:  1/20/2012 
CIK:  0000919722 
Address:  4140 DUBLIN BLVD
SUITE 200
 
City, State, Zip:  DUBLIN, California 94568 
Telephone:  (925) 560-0100 
Fiscal Year:  12/31 
Description of Business
We incorporated in March 1991 as a California corporation and changed our state of incorporation to Delaware in May 1997. We changed our name from SuperGen, Inc. to Astex Pharmaceuticals, Inc. in September 2011. Our executive offices are located at 4140 Dublin Blvd., Suite 200, Dublin, CA, 94568 and our telephone number at that address is (925) 560-0100. We maintain a website on the internet at www.astx.com. This is a textual reference only. We do not incorporate the information on our website into this annual report on Form 10-K, and you should not consider any information on, or that can be accessed through, our website as part of this annual report on Form 10-K. Overview We are dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology and hematology. We are developing a pipeline of novel medicines for partnership with leading pharmaceutical companies.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into Material Definitive Agreement
      Item 1.02. Termination of a Material Definitive Agreement
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 99.1
  EXHIBIT 99.2
  EXHIBIT 99.3
BROKERAGE PARTNERS